Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate

Abstract

Bisphosphonate, a potent anti-resorptive agent, is generally accepted as a safe, effective, well tolerated treatment for postmenopausal osteoporosis. Atypical femoral fracture (AFF) and bisphosphonate related osteonecrosis of jaw (BRONJ) are the increasing morbidities in patients treated with long term bisphosphonate. Pathogenic mechanisms of AFF and BRONJ are not fully identified and not identical. We report a case of BRONJ followed by AFF and its nonunion in a 67-year-old woman patient receiving an oral bisphosphonate during 7 years for the treatment of osteoporosis.

DOI: 10.11005/jbm.2014.21.2.155

Extracted Key Phrases

4 Figures and Tables

Cite this paper

@inproceedings{Won2014AtypicalFF, title={Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate}, author={Yougun Won and Joon-Ryul Lim and Young-Hwan Kim and Hyung-keun Song and Kyu Hyun Yang}, booktitle={Journal of bone metabolism}, year={2014} }